Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

Transkaryotic Therapies receives patent for Gene Activation technology

April 8, 1998

No Comments

Targeted Genetics announces collaboration with NHLBI

April 7, 1998

No Comments

Genetronics' EPT plus bleomycin looks effective in prostate cancer

April 6, 1998

No Comments

Inhale reports successful phase I and II results with drugs from Baxter collaboration

April 6, 1998

No Comments

U.S. patent issues for GenVec's advanced gene therapy vectors

April 3, 1998

No Comments

TAPET efficacy reported at AACR meeting

April 2, 1998

No Comments

Novel liposomal delivery system available for licensing from NCI/NIH

April 2, 1998

No Comments

NIH offers gene expression detection technology for licensing

March 30, 1998

No Comments

Demeter granted U.S. patent for peptide stabilization

March 30, 1998

No Comments

PIN*POINT method available for licensing from NIH

March 27, 1998

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Drug design, drug delivery and technologies, BioWorld Science
RSS

Transkaryotic Therapies receives patent for Gene Activation technology

Targeted Genetics announces collaboration with NHLBI

Genetronics' EPT plus bleomycin looks effective in prostate cancer

Inhale reports successful phase I and II results with drugs from Baxter collaboration

U.S. patent issues for GenVec's advanced gene therapy vectors

TAPET efficacy reported at AACR meeting

Novel liposomal delivery system available for licensing from NCI/NIH

NIH offers gene expression detection technology for licensing

Demeter granted U.S. patent for peptide stabilization

PIN*POINT method available for licensing from NIH

Today's news in brief

Today's news in brief

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

Australia’s Celosia heads toward clinic with gene therapy for ALS

Sangamo stock plunges as Pfizer leaves hemophilia partnership

Drug design, drug delivery and technologies, BioWorld Science RSS

Drug design, drug delivery and technologies, BioWorld Science
RSS